BMJ  2004;328:991 (24 April), doi:10.1136/bmj.38042.506748.EE (published 19 March 2004)

Primary care

Systematic review of topical capsaicin for the treatment of chronic pain

Lorna Mason, research associate1, R Andrew Moore, director of research1, Sheena Derry, senior researcher1, Jayne E Edwards, senior researcher1, Henry J McQuay, professor of pain relief1

1 Pain Research and Nuffield Department of Anaesthetics, University of Oxford, Oxford Radcliffe Hospital, Headington, Oxford OX3 7LJ

Correspondence to: R A Moore andrew.moore{at}pru.ox.ac.uk

Objective To determine the efficacy and safety of topically applied capsaicin for chronic pain from neuropathic or musculoskeletal disorders.

Data sources Cochrane Library, Medline, Embase, PubMed, an in-house database, and contact with manufacturers of topical capsaicin.

Study selection Randomised controlled trials comparing topically applied capsaicin with placebo or another treatment in adults with chronic pain.

Data extraction Primary outcome was dichotomous information for the number of patients with about a 50% reduction in pain. Outcomes were extracted at four weeks for musculoskeletal conditions and eight weeks for neuropathic conditions. Secondary outcomes were adverse events and withdrawals due to adverse events.

Data synthesis Six double blind placebo controlled trials (656 patients) were pooled for analysis of neuropathic conditions. The relative benefit from topical capsaicin 0.075% compared with placebo was 1.4 (95% confidence interval 1.2 to 1.7) and the number needed to treat was 5.7 (4.0 to 10.0). Three double blind placebo controlled trials (368 patients) were pooled for analysis of musculoskeletal conditions. The relative benefit from topical capsaicin 0.025% or plaster compared with placebo was 1.5 (1.1 to 2.0) and the number needed to treat was 8.1 (4.6 to 34). Around one third of patients experienced local adverse events with capsaicin, which would not have been the case with placebo.

Conclusions Although topically applied capsaicin has moderate to poor efficacy in the treatment of chronic musculoskeletal or neuropathic pain, it may be useful as an adjunct or sole therapy for a small number of patients who are unresponsive to, or intolerant of, other treatments.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Topical capsaicin may be a useful adjunct in chronic pain...
BMJ 2004 328: 0. [Full Text]

A commentary on commentaries
Richard Smith
BMJ 2004 328: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Ziegler, D. (2009). Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?. Diabetes Care 32: S414-S419 [Full text]  
  • Rutkove, S. B. (2009). A 52-Year-Old Woman With Disabling Peripheral Neuropathy: Review of Diabetic Polyneuropathy. JAMA 302: 1451-1458 [Abstract] [Full text]  
  • Kissin, I. (2008). Vanilloid-Induced Conduction Analgesia: Selective, Dose-Dependent, Long-Lasting, with a Low Level of Potential Neurotoxicity. Anesth. Analg. 107: 271-281 [Abstract] [Full text]  
  • Barron, M. C., Rubin, B. R. (2007). Managing Osteoarthritic Knee Pain. JAOA: Journal of the American Osteopathic Association 107: ES21-ES27 [Abstract] [Full text]  
  • Wassell, R. W., Adams, N., Kelly, P. J. (2006). The treatment of temporomandibular disorders with stabilizing splints in general dental practice: One-year follow-up.. Journal of the American Dental Association 137: 1089-1098 [Abstract] [Full text]  
  • Rubin, B. R. (2005). Management of Osteoarthritic Knee Pain. JAOA: Journal of the American Osteopathic Association 105: S23-S28 [Abstract] [Full text]  
  • Irving, G. A. (2005). Contemporary assessment and management of neuropathic pain. Neurology 64: S21-S27 [Abstract] [Full text]  
  • Lam, P. M. W., McDonald, J., Lambert, D. G. (2005). Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids. Br J Anaesth 94: 649-656 [Abstract] [Full text]  
  • (2004). 23 Apr 2004 to 23 Jul 2004. Evid. Based Nurs. 7: e4-e4 [Full text]  
  • (2004). Other articles noted. Evid. Based Med. 9: e5-e5 [Full text]  
  • Cooper, C., Jordan, K. M (2004). Topical NSAIDs in osteoarthritis. BMJ 329: 304-305 [Full text]  
  • (2004). Topical Capsaicin for Chronic Pain?. Journal Watch Dermatology 2004: 9-9 [Full text]  
  • (2004). Topical Capsaicin for Chronic Pain?. JWatch General 2004: 5-5 [Full text]  
  • Tramer, M. R (2004). It's not just about rubbing--topical capsaicin and topical salicylates may be useful as adjuvants to conventional pain treatment. BMJ 328: 998-998 [Full text]  

Rapid Responses:

Read all Rapid Responses

Clear & Consise article on an important subject!
NYB Mark Medical
bmj.com, 24 Apr 2004 [Full text]
External pain control help
John Madura
bmj.com, 25 Apr 2004 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ